Browsing: Longevity Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for longevity risk analysis, commentary and insights.
While ageing is fundamentally a physiological phenomenon, numerous factors significantly influence the rate at which this process occurs. Certain factors can accelerate the ageing process, while some have the potential to decelerate it, influencing the rate of physiological decline.
Dr. Rahul Nawander, Medical Director at Fasano Underwriting, offers his views on what is impacting LEs generally from a medical perspective.
The different risk exposures and risk appetites of insurance companies mean that reinsurance is used in a number of ways as there is not a ‘one size fits all’ offering.
There are few options available to investors that want exposure to longevity risk in Canada, but a new idea could expand this currently limited market.
The K3 team and brand will continue to operate as a distinct service offering within the Isio group.
All pensions within the CWPF Defined Benefit Scheme are now backed by insurance policies.
The transaction was completed in September 2024 and secures the benefits for approximately 15,000 members of the scheme.
Private equity-backed reinsurers’ appetite for Asian life insurance assets is unlikely to be sated any time soon, as there is $2 trillion of assets/liabilities under management that are currently providing sub-par capital returns
New analysis from consulting firm LCP suggests the value of the €20-30bn of Dutch pension fund liabilities expected to be bought out by insurers by 2027 could differ by at least €500m depending on the model used.
IORP II and DORA making extra work for Irish pension schemes, but activity could soon pick up.